We love to hear from you
At Ncardia we would like to hear all your ideas, challenges and questions, and bring those to a solution that fits your needs. To us, there are no limitations in what we can do for you.Contact us
In order to translate an in vitro cellular model into the correct clinical interpretation of assay read-outs, a fully functional and validated model is needed.
Ncardia iPSC-derived cardiomyocytes and neurons are used in the assessment of safety pharmacology at the pre-clinical stage as well as drug efficacy testing. You can find our cardiomyocytes available as cryopreserved cells, or ready-to-go for specific applications in a CardioPlate™.
hiPSC-derived cardiomyocytes with a fully functional, ventricular phenotype for use in drug discovery and development. They are acquired without genetic modifications, and cultured in a well-defined, serum-free culture medium that enhances their functionality and maturity.
End the struggle in analyzing electrophysiology data when assessing drug effects in human-induced pluripotent stem cell-derived (hiPSC) cardiomyocytes. Ncyte CardioPlate Maestro MEA 96 is a ready-to-use Maestro™ MEA 96-well plate containing hiPSC-differentiated cardiomyocytes and medium.
Pluricyte® Cardiomyocytes on a Maestro 96 well MEA plate for MEA assays
Cryopreserved hiPSC-derived central nervous system neuron cells and astrocytes for central nervous neurotoxicity assays, CNS disease studies, such as seizure, and CNS disease modeling.
Ncardia offers custom manufacturing of iPSC-derived cell models for application in drug discovery and development. Contact us to discuss custom manufacturing of your required cell type.